The Japan Patent Office Grants Patent
Check out our recent White Paper on SPA™! Rationalised formulation development using less than 1 milligram of API!
Sounding too good to be true? Check out our follow-up White Paper on SPA™ solubility data assisted formulation modelling, a collaborative work between The Solubility Company and amofor!
Following on from our well received eChalk by our CEO Sami Svanbäck, hosted by the AAPS we are excited to release our new White Paper on SPA™ Dissolution Rate Assays
Check out our recent White Paper on SPA™ solubility data assisted modelling, a collaborative work together with another exciting startup amofor!
China National Intellectual Property Administration grants Patent!
The extended performance comparison between the SPA™ assay and the industry standard shake-flask assay highlights the benefits of small- scale measurement without sacrificing accuracy.
SPA™ highlighted as an innovative solubility measurement technology addressing the gap at the discovery-development interface.
Researchers at Eli Lilly and Company, AstraZeneca, Novartis, and Pfizer recently highlighted the critical role of solubility measurement in drug discovery and development, addressing the current gap at the discovery-development interface. “Solubility is a key physicochemical property for the success of any drug candidate” but “an artificial boundary can exist at the discovery-development interface”. The […]
All the team at The Solubility Company wishes a Happy Holidays and a prosperous 2022 to all our friends and collaborators around the world! In the past year we have continued to grow with the help of our Clients and Collaborators, whilst redefining solubility analysis with new service offerings and we are looking forward to […]
The Solubility Company granted another US patent for our breakthrough SPA™ technology!
We are delighted to attend and present a poster at PharmSci360 this year both in person and virtually.